Cereno Scientific participates at the scientific conference PVRI 2024 Annual Congress to further build presence in the Pulmonary Hypertension community
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company will participate in the PVRI 2024 Annual Congress organized by the Pulmonary Vascular Research Institute. The event is held on January 31 – February 3, 2024, in London, UK. The PVRI 2024 Annual Congress: “The next 50 years of pulmonary hypertension - a global view” is a top pulmonary vascular congress globally.“Participating at a key pulmonary vascular congress such as PVRI is an important aspect of our strategy to continue